VeriSign Inc.(NASDAQ:VRSN) is attracting noteworthy attention in the biotech industry. Adjusting share positions, various asset management institutions such as
KLP Kapitalforvaltning AS and
TD Asset Management Inc. have actively engaged in stock transactions. VeriSign reportedly outperforms Nasdaq and is among Warren Buffet’s longest-held stocks. Other significant purchases include,
Sei Investments Co., United Super Pty Ltd, Raymond James Financial Inc., and Mizuho Securities USA LLC.
Vanguard Group Inc. maintains a $2.15 Billion stock position.
VeriSign also recently set a new 52-week high further solidifying investor optimism relating to the company's performance. The asset holdings of other notable firms such as
Vinva Investment Management Ltd and
Corient Private Wealth LLC exceed million-dollar figures.In recent news,
VeriSign Q4 earnings were in line with expectations further solidifying its stance as a formidable player in e-commerce software stocks. The increasing stake by
Berkshire Hathaway fuels bullish momentum in the company’s stock. However, the retirement of
George E. Kilguss III, Executive Vice President and Chief Financial Officer, heralds a key shift in leadership at
VeriSign. The company has consistently achieved robust growth and set high stock values, recently hitting a 52-week high at $240.22.
Verisign VRSN News Analytics from Wed, 18 Sep 2024 07:00:00 GMT to Fri, 28 Mar 2025 09:46:26 GMT -
Rating 8
- Innovation 5
- Information 10
- Rumor -3
